Welcome From the Chair

Welcome From The Chair

“It is my pleasure to welcome you to the Department of Pathology and Laboratory Medicine at New York Presbyterian Hospital – Weill Cornell Medical Center, one of the truly excellent pathology departments in the United States. We are fortunate to be based in the Weill Cornell Medical College, a small but prestigious Ivy League medical school, and in New York – Presbyterian Hospital, one of the top ranked hospitals in the United States.

Our mission is to integrate medial science...   [Read the full message from the chair]


Find a Faculty Member

News & Highlights

Weill Cornell Pathologists "SuperDocs" NYTimes 2013

Dr. Attilio Orazi and Daniel Knowles were selected for inclusion in the 2013 New York Super Doctors

 

Residents Research Day
Thursday, April 11, 2013

Oral presentations, digital photo contest and posters.
For details click here

 

Stopping and Starting Cancer Cell Cycle Weakens and Defeats Multiple Myeloma

New Strategy by Weill Cornell Researchers Wreaks Havoc on Cancer's Central Growth Mechanism

Dr. Chen-Kiang and her laboratory colleagues have long studied genes and proteins that control the cell cycle and cell suicide (apoptosis) in cancer. Cancer is fundamentally a disease of uncontrolled cell proliferation, where cells are able to continuously divide. In contrast, cell division in a healthy individual is regulated by the cell cycle, an orderly sequence of programmed gene expression in which the cell is driven through various checkpoints by a highly regulated network of proteins. Read more

 
 

Stopping and Starting Cancer Cell Cycle Weakens and Defeats Multiple Myeloma

New Strategy by Weill Cornell Researchers Wreaks Havoc on Cancer's Central Growth Mechanism

Dr. Chen-Kiang and her laboratory colleagues have long studied genes and proteins that control the cell cycle and cell suicide (apoptosis) in cancer. Cancer is fundamentally a disease of uncontrolled cell proliferation, where cells are able to continuously divide. In contrast, cell division in a healthy individual is regulated by the cell cycle, an orderly sequence of programmed gene expression in which the cell is driven through various checkpoints by a highly regulated network of proteins. Read more

 
 

Scientists Discover Distinct Molecular Subtype of Prostate Cancer

group effort in collaboration with Dr. Mark Rubin's Laboratory and the Broad Institute, published in Nature Genetics
Read More

 

Mark Rubin, MD part of "Dream Team" in Metastatic Prostate Cancer.

"Understanding the mutational landscape of individual tumors will allow us to better manage metastatic prostate cancers like castration-resistant prostate cancer," explains Dr. Mark A. Rubin, the project's principal investigator at Weill Cornell Medical College. The overarching goal of the grant is to eventually "position CRPC as a manageable and treatable disease with personalized medicine."
Read More

 

Dr. Mark A. Rubin to Provide Insights From Genomic Approaches to Oncology Discovery

Mark A. Rubin, MD, this year’s keynote speaker, is vice chair for experimental research, professor of pathology and laboratory medicine, and the Homer T. Hirst Professor of oncology in pathology at the Weill Cornell Medical College in New York City. Formerly, he was director of genitourinary pathology at the University of Michigan and the Brigham and Women’s Hospital in Boston. Read More